Galapagos NV
GLPG
#4540
Rank
NZ$3.70 B
Marketcap
NZ$56.25
Share price
-0.73%
Change (1 day)
36.22%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): NZ-$0.80

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is NZ-$0.56. In 2024 the company made an earnings per share (EPS) of NZ$1.94 a decrease over its 2023 EPS that were of NZ$5.89.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.80-141.12%
2024NZ$1.94-67.16%
2023NZ$5.89-199.64%
2022NZ-$5.9199.03%
2021NZ-$2.97-68.98%
2020NZ-$9.58-298.06%
2019NZ$4.84-554.64%
2018NZ-$1.06-77.18%
2017NZ-$4.66-326.21%
2016NZ$2.06-134.19%
2015NZ-$6.03-371.34%
2014NZ$2.22-445.98%
2013NZ-$0.6432.88%
2012NZ-$0.48-82.07%
2011NZ-$2.70-817.9%
2010NZ$0.3812.73%
2009NZ$0.33-120.79%
2008NZ-$1.60-37.67%
2007NZ-$2.5739.64%
2006NZ-$1.8428.17%
2005NZ-$1.446.25%
2004NZ-$1.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.33-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.38-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.24-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.15-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$12.61-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$5.04-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$5.97-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
NZ-$1.01 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.05-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel